Suven Life Sciences Ltd Performance
Day's Low
Day's High
₹133.35Day's Price Range₹144.652 Week's Low
52 Week's High
₹74.552-Week Price Range₹169.3
| Returns % | |
| 1 Month Return | + 20.08 % |
| 3 Month Return | -6.03 % |
| 1 Year Return | + 80.29 % |
| Market Stats | |
| Previous Close | ₹141.80 |
| Open | ₹140.50 |
| Volume | 2.40L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹3,132.85Cr |
Suven Life Sciences Ltd Key Statistics
| P/E Ratio | -21.16 |
| PEG Ratio | 22.28 |
| Market Cap | ₹3,132.85 Cr |
| P/B Ratio | 2.57 |
| EPS | -4.82 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | -2.36 |
Suven Life Sciences Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹3,132.85 Cr | 169.83% | 0.50 | -₹106 Cr | ₹11 Cr | |
| BUY | ₹2,516.20 Cr | 26.72% | 0.56 | ₹83 Cr | ₹933 Cr | |
| NA | ₹324.53 Cr | 1.26% | 0.50 | NA | NA | |
| NA | ₹4,596.79 Cr | 240.16% | 0.56 | NA | NA | |
| BUY | ₹30,463.18 Cr | 34.2% | 0.55 | ₹326 Cr | ₹2,694 Cr |
About Suven Life Sciences Ltd
Share Price: ₹134.72 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹3,132.85Cr as of today
Revenue: ₹2.57Cr as on September 2024 (Q3 24)
Net Profit: ₹-49.64Cr as on September 2024 (Q3 24)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
| Organisation | Suven Life Sciences Ltd |
| Headquarters | Hyderabad |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Suven Life Sciences Ltd
Suven Acquires Majority Stake in NJ Bio - 09 Dec, 2024
Suven Life Sciences will acquire a 56% stake in US-based NJ Bio, investing $64.4 million, including $15 million for growth initiatives, strengthening its position in ADC technology.Suven Pharmaceuticals Acquires Controlling Stake in NJ Bio - 07 Dec, 2024
Suven Pharmaceuticals has acquired a controlling stake in NJ Bio Inc. for $64.4 million, enhancing its ADC offerings. This strategic move aligns with Suven's vision to lead in technology-led CDMO solutions, particularly in the ADC/XDC segment, which has positively impacted over 100,000 patients.
Insights on Suven Life Sciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 5.01 Cr → 6.61 Cr (in ₹), with an average increase of 24.2% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SUVEN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 28.12% to 28.34% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, SUVEN stock has moved up by 18.8%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 70.27% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 67.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -26.54 Cr → -49.64 Cr (in ₹), with an average decrease of 41.3% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.45% to 0.34% in Sep 2024 quarter
Suven Life Sciences Ltd Financials
Index Inclusions
Suven Life Sciences Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 70.27% | 0.00 | |
| Foreign Institutions | 0.34% | ||
| Mutual Funds | 1.05% | 0.04 | |
| Retail Investors | 28.34% | 0.80 | |
| Others | 0% |
Suven Life Sciences Ltd Key Indicators
Suven Life Sciences Ltd Valuation
Suven Life Sciences Ltd in the last 5 years
Lowest (-165.11x)
February 27, 2020
Today (-21.16x)
December 19, 2024
Industry (105.00x)
December 19, 2024
Highest (-6.67x)
March 27, 2023
Suven Life Sciences Ltd Earnings and Dividends
Suven Life Sciences Ltd Earnings Results
Suven Life Sciences Ltd’s net profit fell -291.48% since last year same period to ₹-49.64Cr in the Q2 2024-2025. On a quarterly growth basis, Suven Life Sciences Ltd has generated -77.03% fall in its net profits since last 3-months.
Read More about Earnings ResultsSuven Life Sciences Ltd Dividends February,2019
In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 - translating a dividend yield of 1.11%.
Read More about Dividends
Suven Life Sciences Ltd Technicals Summary
Bearish
Neutral
Bullish
Suven Life Sciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Suven Life Sciences Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Suven Life Sciences Ltd shares.
Suven Life Sciences Ltd (SUVEN) share price today is ₹134.72
Suven Life Sciences Ltd is listed on NSE
Suven Life Sciences Ltd is listed on BSE
- Today’s highest price of Suven Life Sciences Ltd is ₹144.6.
- Today’s lowest price of Suven Life Sciences Ltd is ₹133.35.
PE Ratio of Suven Life Sciences Ltd is -21.16
PE ratio = Suven Life Sciences Ltd Market price per share / Suven Life Sciences Ltd Earnings per share
Today’s traded volume of Suven Life Sciences Ltd(SUVEN) is 2.40L.
Today’s market capitalisation of Suven Life Sciences Ltd(SUVEN) is ₹3132.85Cr.
| Suven Life Sciences Ltd(SUVEN | Price |
|---|---|
52 Week High | ₹169.3 |
52 Week Low | ₹74.5 |
Suven Life Sciences Ltd(SUVEN) share price is ₹134.72. It is down -20.43% from its 52 Week High price of ₹169.3
Suven Life Sciences Ltd(SUVEN) share price is ₹134.72. It is up 80.83% from its 52 Week Low price of ₹74.5
| Suven Life Sciences Ltd(SUVEN | Returns |
|---|---|
1 Day Returns | -7.08% |
1 Month Returns | 20.08% |
3 Month Returns | -6.03% |
1 Year Returns | 80.29% |